These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 13727350)
1. Excretion and distribution studies with radioisotope-labeled alkylating drugs in cancer patients. NADKARNI MV; TRAMS EG; SMITH PK Cancer; 1961; 14():953-6. PubMed ID: 13727350 [No Abstract] [Full Text] [Related]
2. Distribution and fate of alkylating agents. SMITH PK; NADKARNI MV; DAVISON C; TRAMS EG Ann N Y Acad Sci; 1958 Apr; 68(3):834-50; discussion 850-2. PubMed ID: 13627736 [No Abstract] [Full Text] [Related]
3. Mode of action of alkylating agents: formation of S-ethylcysteine from ethyl methanesulphonate in vivo. ROBERTS JJ; WARWICK GP Nature; 1957 Jun; 179(4571):1181-2. PubMed ID: 13440933 [No Abstract] [Full Text] [Related]
4. [COMPARISONS OF RADIOISOTOPE TREATMENTS AND CURRENT PROBLEMS IN CHEMOTHERAPY OF CANCER]. BERKMAN AT Turk Tip Cemiy Mecm; 1964 Mar; 30():124-43. PubMed ID: 14143554 [No Abstract] [Full Text] [Related]
5. Diversity of penetration of anti-cancer agents into solid tumours. Simpson-Herren L; Noker PE Cell Prolif; 1991 Jul; 24(4):355-65. PubMed ID: 1863674 [TBL] [Abstract][Full Text] [Related]
6. [Absorption, distribution and excretion of (carboxy-14C)bisbromoacetyl hexestrol]. Ling YH; Hua Z; Sun SY; Liang YY Zhongguo Yao Li Xue Bao; 1984 Jun; 5(2):109-11. PubMed ID: 6087610 [No Abstract] [Full Text] [Related]
7. The role of radioactive isotopes and alkylating agents in the treatment of malignant effusions. REEVE TS; MYHILL J Med J Aust; 1962 Aug; 49(2)():245-9. PubMed ID: 14491011 [No Abstract] [Full Text] [Related]
8. REVIEW OF CHEMOTHERAPEUTIC AGENTS AND RADIOISOTOPES IN THE NONOPERATIVE TREATMENT OF GYNECOLOGIC CANCERS. SHERMAN AI J Int Coll Surg; 1965 Mar; 43():259-65. PubMed ID: 14261310 [No Abstract] [Full Text] [Related]
9. Comparative biodistribution and metabolism of carbon-11-labeled N-[2-(dimethylamino)ethyl]acridine-4-carboxamide and DNA-intercalating analogues. Osman S; Rowlinson-Busza G; Luthra SK; Aboagye EO; Brown GD; Brady F; Myers R; Gamage SA; Denny WA; Baguley BC; Price PM Cancer Res; 2001 Apr; 61(7):2935-44. PubMed ID: 11306471 [TBL] [Abstract][Full Text] [Related]
11. STUDY ON THE DISTRIBUTION AND METABOLISM OF 82BR-LABELLED DIBROMOMANNITOL (DBM) IN NORMAL AND TUMOR-BEARING RATS. INSTITORIS L; HORVATH IP; CSANYI E Neoplasma; 1964; 11():245-55. PubMed ID: 14171419 [No Abstract] [Full Text] [Related]
12. Biochemistry of drugs 13. Substances with antineoplastic activity. XXX. Cancerostatic activity, absorption, tissue distribution and excretion of ethylester N--delta-(6-purinylthio)valeryl-glycine-35S-(butocine) in micel. Ráz K; Francová V; Franc Z; Cerný A; Jelínek V; Semonský M Neoplasma; 1969; 16(4):397-402. PubMed ID: 5344226 [No Abstract] [Full Text] [Related]
13. EPEG, a new antineoplastic epipodophyllotoxin. Creaven PJ; Allen LM Clin Pharmacol Ther; 1975 Aug; 18(2):221-6. PubMed ID: 1157446 [TBL] [Abstract][Full Text] [Related]
14. General principles of cancer chemotherapy. Einhorn LH Conn Med; 1976 Mar; 40(3):159-68. PubMed ID: 765057 [No Abstract] [Full Text] [Related]
15. [Clinical pharmacology of anticancer agents. (Part 1) Introduction, alkylating agents and platinum compounds]. Fujita H Gan To Kagaku Ryoho; 1991 Nov; 18(14):2481-7. PubMed ID: 1952967 [TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacology of isophosphamide. Creaven PJ; Allen LM; Alford DA; Cohen MH Clin Pharmacol Ther; 1974 Jul; 16(1):77-86. PubMed ID: 4602057 [No Abstract] [Full Text] [Related]
17. Radioactive isotopes in the control of intraarterial chemotherapy. Erjavec M; Auersperg M; Obrez I Radiobiol Radiother (Berl); 1971; 12(2):219-25. PubMed ID: 5157027 [No Abstract] [Full Text] [Related]
18. Carrier-dependent and carrier-independent transport of anti-cancer alkylating agents. Byfield JE; Calabro-Jones PM Nature; 1981 Nov; 294(5838):281-3. PubMed ID: 6975441 [No Abstract] [Full Text] [Related]
19. Biochemistry of drugs. XII. Absorption, tissue distribution and excretion of 4-hydroxy-5-fluoropyrimidine-6-14C in mice. Francová V; Ráz K; Franc Z; Sváb A; Budĕsínsk0y Z; Jelínek V Neoplasma; 1968; 15(1):71-6. PubMed ID: 5655611 [No Abstract] [Full Text] [Related]
20. Absorption, tissue distribution, and excretion of the anti-neoplastic agent guanazole in the rat. Musa MN; Lower GM; Welling PG; Johnson BM; Kaiman BD; Bryan GT Res Commun Chem Pathol Pharmacol; 1974 Mar; 7(3):497-512. PubMed ID: 4824824 [No Abstract] [Full Text] [Related] [Next] [New Search]